Apolipoprotein A-V is a Potent Modulator of HDL and VLDL Components in Preadolescent Children

被引:5
作者
Abe, Yuriko [1 ]
Okada, Tomoo [1 ]
Kuromori, Yuki [1 ]
Hara, Mitsuhiko [2 ]
Saito, Emiko [2 ]
Iwata, Fujihiko [1 ]
Harada, Kensuke [1 ]
Mugishima, Hideo [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Itabashi Ku, Tokyo 1738610, Japan
[2] Tokyo Metropolitan Hiroo Gen Hosp, Dept Pediat, Tokyo, Japan
关键词
Apolipoprotein A-V; Large HDL particles; Hypertriglyceridemia; VLDL-TG; TRIGLYCERIDE-RICH LIPOPROTEINS; METABOLIC SYNDROME; TRANSGENIC MICE; APOA5; ATHEROSCLEROSIS; ASSOCIATION; HYDROLYSIS; DEFICIENCY; SERUM; RISK;
D O I
10.5551/jat.E356
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: Mice lacking apolipoprotein A-V (apoA-V) displayed an increase in serum triglyceride (TG) levels; however, the correlation of apoA-V levels with TG levels in humans is controversial, and the exact mechanism by which apoA-V affects TG levels is unclear. The aim of the present study was to clarify the impact of apoA-V on the lipoprotein subclass profile in preadolescent children, which has not been studied. Method: The study subjects were 178 (89 male, 89 female) 4th grade elementary school children (mean +/- SD: 9.5 +/- 0.5 years old). ApoA-V levels were determined by an enzyme-linked immunosorbent assay, and the lipid component of each lipoprotein fraction and their particle sizes were measured by HPLC. Results: Levels of apoA-V showed no gender difference in preadolescent children, and were not affected by anthropometric variables. ApoA-V had a negative association with serum TG levels and TG levels in each lipoprotein fraction, and a positive association with HDL-C. In particular, apoA-V appears to contribute to the increase in cholesterol levels in the larger HDL fraction. Conclusions: It was suggested that apoA-V is a potent modulator of HDL and VLDL components in preadolescent children.
引用
收藏
页码:121 / 126
页数:6
相关论文
共 29 条
  • [1] Apolipoprotein composition of HDL in cholesteryl ester transfer protein deficiency
    Asztalos, BF
    Horvath, KV
    Kajinami, K
    Nartsupha, C
    Cox, CE
    Batista, M
    Schaefer, EJ
    Inazu, A
    Mabuchi, H
    [J]. JOURNAL OF LIPID RESEARCH, 2004, 45 (03) : 448 - 455
  • [2] Altered apolipoprotein A-V expression during the acute phase response is independent of plasma triglyceride levels in mice and humans
    Becker, S
    Schomburg, L
    Renko, K
    Tölle, M
    van der Giet, M
    Tietge, UJF
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 339 (03) : 833 - 839
  • [3] High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase
    Berard, AM
    Foger, B
    Remaley, A
    Shamburek, R
    Vaisman, BL
    Talley, G
    Paigen, B
    Hoyt, RF
    Marcovina, S
    Brewer, HB
    SantamarinaFojo, S
    [J]. NATURE MEDICINE, 1997, 3 (07) : 744 - 749
  • [4] APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency
    Calandra, S
    Oliva, CP
    Tarugi, P
    Bertolini, S
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (02) : 122 - 127
  • [5] Variants at the APOA5 locus, association with carotid atherosclerosis, and modification by obesity:: the Framingham Study
    Elosua, Roberto
    Ordovas, Jose M.
    Cupples, L. Adrienne
    Lai, Chao-Qiang
    Demissie, Serkalem
    Fox, Caroline S.
    Polak, Joseph F.
    Wolf, Philip A.
    D'Agostino, Ralph B., Sr.
    O'Donnell, Christopher J.
    [J]. JOURNAL OF LIPID RESEARCH, 2006, 47 (05) : 990 - 996
  • [6] Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren
    Endo, K
    Yanagi, H
    Araki, J
    Hirano, C
    Yamakawa-Kobayashi, K
    Tomura, S
    [J]. HUMAN GENETICS, 2002, 111 (06) : 570 - 572
  • [7] Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5
    Fruchart-Najib, J
    Baugé, E
    Niculescu, LS
    Pham, T
    Thomas, B
    Rommens, C
    Majd, Z
    Brewer, B
    Pennacchio, LA
    Fruchart, JC
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (02) : 397 - 404
  • [8] APOA5 variants and metabolic syndrome in Caucasians
    Grallert, Harald
    Sedlmeier, Eva-Maria
    Huth, Cornelia
    Kolz, Melanie
    Heid, Iris M.
    Meisinger, Christa
    Herder, Christian
    Strassburger, Klaus
    Gehringer, Anke
    Haak, Markus
    Giani, Guido
    Kronenberg, Florian
    Wichmann, H-Erich
    Adamski, Jerzy
    Paulweber, Bernhard
    Illig, Thomas
    Rathmann, Wolfgang
    [J]. JOURNAL OF LIPID RESEARCH, 2007, 48 (12) : 2614 - 2621
  • [9] Apolipoprotein A-V deficiency results in marked hypertriglyceridemia attributable to decreased lipolysis of triglyceride-rich lipoproteins and removal of their remnants
    Grosskopf, I
    Baroukh, N
    Lee, SJ
    Kamari, Y
    Harats, D
    Rubin, EM
    Pennacchio, LA
    Cooper, AD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (12) : 2573 - 2579
  • [10] Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease
    Hirano, Tsutomu
    Hayashi, Toshiyuki
    Adachi, Mitsuru
    Taira, Takayasu
    Hattori, Hiroaki
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2007, 56 (04): : 462 - 463